Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30152% above fair value
$319.09−3.85 (-1.19%)
Close on Nov 13, 2026Market cap $46.00BP/E –Yield –
Natera enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Natera's enterprise value was $44.92B on Nov 11, 2026, against $31.88B a year earlier. Over the last 5 years it ranged from $2.48B to $58.49B, with a median of $12.22B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $44.92B | +47.1% |
| 2025 | Dec 31, 2025 | $30.55B | +62.4% |
| 2024 | Dec 31, 2024 | $18.81B | +185.1% |
| 2023 | Dec 29, 2023 | $6.60B | +91.9% |
| 2022 | Dec 30, 2022 | $3.44B | -56.2% |
| 2021 | Dec 31, 2021 | $7.86B | +1.7% |
| 2020 | Dec 31, 2020 | $7.73B | +223.9% |
| 2019 | Dec 31, 2019 | $2.39B | +173.6% |
| 2018 | Dec 31, 2018 | $871.99M | +67.1% |
| 2017 | Dec 29, 2017 | $521.72M | -15.5% |
| 2016 | Dec 30, 2016 | $617.11M | +79.8% |
| 2015 | Dec 31, 2015 | $343.28M | – |
See a number that looks wrong?